Article Information
History
- August 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Department of Medicine, Division of Pulmonary, Allergy, and Critical Care, Columbia University Irving Medical Center, New York, NY
- 2Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, NY
- ↵†
Corresponding Authors
: Peter B Bach, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center 1275 York Avenue, NYC, NY 10065 Email: bachp{at}maskcc.org, Matthew R Baldwin, Assistant Professor, Columbia University Irving Medical Center 622 West 168th Street, PH8E-101, NYC, NY 10032 Email: mrb45{at}cumc.columbia.edu
↵* Indicates that these authors contributed equally to this work
Posted August 12, 2020.
Hospital length of stay for severe COVID-19 patients: implications for Remdesivir’s value
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos